Stem Cell
Research Areas
Products Related to Stem Cell(471)
- GC50489NLS-StAx-hCAS: 2872559-21-0Purity: >98%
Wnt signaling inhibitor; inhibits β-catenin-transcription factor interactions
- GC60348SupinoxinCAS: 888478-45-3Purity: >99.50%
Supinoxin (RX-5902) is an orally active inhibitor of phosphorylated-p68 RNA helicase (P-p68) and a potent first-in-class anti-cancer agent. Supinoxin interacts with Y593 phosphorylated-p68 and attenuates the nuclear shuttling of β-catenin. Supinoxin induces cell apoptosis and inhibits growth of TNBC cancer cell lines with IC50s ranging from 10 nM to 20 nM.
- GC61233RBPJ Inhibitor-1CAS: 2682114-39-0Purity: >99.50%
RBPJ Inhibitor-1 (RIN1), the first RBPJ inhibitor, blocks the functional interaction of RBPJ with SHARP. RBPJ Inhibitor-1 (RIN1) inhibits NOTCH-dependent tumor cell proliferation.
- GC61527Lats-IN-1CAS: 1424635-83-5Purity: >98.00%
LATS-IN-1 is an inhibitor of LATS1 and LATS2 (IC 50 = 2nM for both). Lats-IN-1 inhibits core Hippo pathway kinases and activates downstream effector molecules YAP/TAZ, which translocate to the nucleus, driving expression of genes that promote cell proliferation and survival. Lats-IN-1 is primarily used to treat tissue regeneration and degenerative diseases.
- GC61861Oct3/4-inducer-1CAS: 1016535-83-3Purity: >98.00%
Oct3/4-inducer-1 (compound 2) is a potent Oct3/4 inducer.
- GC62394TeplinovivintCAS: 1428064-91-8Purity: >99.50%
Teplinovivint is a potent wnt/β-catenin signaling pathway inhibitor.
- GC62432β-catenin-IN-2CAS: 1458664-10-2Purity: >99.50%
β-catenin-IN-2 is a potent β-catenin inhibitor, compound H1B1, extracted from patent US20150374662A1. β-catenin-IN-2 can be used for the study of colorectal cancer.
- GC63100N-Desmethylnefopam D5 hydrochloridePurity: >98%
N-Desmethylnefopam D5 hydrochloride is a deuterium labeled N-Desmethylnefopam hydrochloride.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC50489 | NLS-StAx-h | 2872559-21-0 | >98% | |
Wnt signaling inhibitor; inhibits β-catenin-transcription factor interactions | ||||
| GC50624 | FzM1.8 | 2204290-85-5 | >98.00% | |
Frizzled 4 allosteric agonist; exhibits biased siginaling; preserves stemness | ||||
| GC50685 | Dynapyrazole A | 2226517-75-3 | >98.00% | |
| GC50703 | Yhhu 3792 | 2097826-24-7 | >99.00% | |
| GC52376 | BMP2-derived Peptide (trifluoroacetate salt) | - | >95.00% | |
A synthetic peptide | ||||
| GC60348 | Supinoxin | 888478-45-3 | >99.50% | |
Supinoxin (RX-5902) is an orally active inhibitor of phosphorylated-p68 RNA helicase (P-p68) and a potent first-in-class anti-cancer agent. Supinoxin interacts with Y593 phosphorylated-p68 and attenuates the nuclear shuttling of β-catenin. Supinoxin induces cell apoptosis and inhibits growth of TNBC cancer cell lines with IC50s ranging from 10 nM to 20 nM. | ||||
| GC60970 | KY19382 | 2226664-93-1 | >98.00% | |
KY19382 is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β, with IC50s of 19 and 10 nM, respectively. | ||||
| GC61093 | MSAB | 173436-66-3 | >99.00% | |
MSAB (methyl 3-{[(4-methylphenyl)sulfonyl]amino}benzoate) is a selective Wnt/β-catenin signaling inhibitor binding to β-catenin and promoting its degradation with an EC 50 of 0.583μM. | ||||
| GC61205 | PRI-724 | 1422253-38-0 | >99.00% | |
PRI-724 (C-82 prodrug, ICG-001 analog) is a first-in-class Wnt signaling modulator that inhibits the interaction between cAMP response element (CREB) binding protein and β-catenin. | ||||
| GC61233 | RBPJ Inhibitor-1 | 2682114-39-0 | >99.50% | |
RBPJ Inhibitor-1 (RIN1), the first RBPJ inhibitor, blocks the functional interaction of RBPJ with SHARP. RBPJ Inhibitor-1 (RIN1) inhibits NOTCH-dependent tumor cell proliferation. | ||||
| GC61410 | I3MT-3 | 459420-09-8 | >98.00% | |
I3MT-3 (HMPSNE) is a potent, selective, and cell-membrane permeable inhibitor of 3-Mercaptopyruvate sulfurtransferase (3MST) (IC50=2.7 μM). | ||||
| GC61527 | Lats-IN-1 | 1424635-83-5 | >98.00% | |
LATS-IN-1 is an inhibitor of LATS1 and LATS2 (IC 50 = 2nM for both). Lats-IN-1 inhibits core Hippo pathway kinases and activates downstream effector molecules YAP/TAZ, which translocate to the nucleus, driving expression of genes that promote cell proliferation and survival. Lats-IN-1 is primarily used to treat tissue regeneration and degenerative diseases. | ||||
| GC61781 | Super-TDU | 1599441-71-0 | >98.50% | |
Super-TDU is a specific YAP antagonist targeting YAP-TEADs interaction. Super-TDU suppresses tumor growth in gastric cancer mouse model. | ||||
| GC61861 | Oct3/4-inducer-1 | 1016535-83-3 | >98.00% | |
Oct3/4-inducer-1 (compound 2) is a potent Oct3/4 inducer. | ||||
| GC62132 | K-975 | 2563855-03-6 | >98.00% | |
K-975 is a potent and orally active inhibitor of YAP1/TAZ-TEAD protein-protein interaction. | ||||
| GC62214 | FIDAS-3 | 1266684-01-8 | >99.00% | |
FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities. | ||||
| GC62258 | SAG-d3 | - | >98.50% | |
SAG-d3 is deuterium labeled SAG. SAG is a potent Smoothened (Smo) receptor agonist (EC50=3 nM; Kd=59 nM). | ||||
| GC62394 | Teplinovivint | 1428064-91-8 | >99.50% | |
Teplinovivint is a potent wnt/β-catenin signaling pathway inhibitor. | ||||
| GC62424 | PY-60 | 2765218-56-0 | >98.00% | |
PY-60 is a thiazole-substituted derivative with 5-phenylisoxazole as its core structure, which can potently and specifically activate the transcriptional activity of YAP (EC 50 = 1.6μM). | ||||
| GC62432 | β-catenin-IN-2 | 1458664-10-2 | >99.50% | |
β-catenin-IN-2 is a potent β-catenin inhibitor, compound H1B1, extracted from patent US20150374662A1. β-catenin-IN-2 can be used for the study of colorectal cancer. | ||||
| GC62524 | VT107 | 2417718-63-7 | >99.50% | |
VT-107, as an analogous to VT104, is an orally active and potent pan-TEAD auto-palmitoylation inhibitor. VT-107 can be used for the research of cancer. | ||||
| GC63088 | MYF-01-37 | 2416417-65-5 | >98.50% | |
MYF-01-37 is a covalent TEAD inhibitor targeting Cys380. MYF-01-37 has a reversible inhibition on YAP/TEAD interaction. | ||||
| GC63100 | N-Desmethylnefopam D5 hydrochloride | - | >98% | |
N-Desmethylnefopam D5 hydrochloride is a deuterium labeled N-Desmethylnefopam hydrochloride. | ||||
| GC63257 | VT103 | 2290608-13-6 | >99.00% | |
VT103 is a selective TEAD1 protein palmitoylation inhibitor. | ||||
